+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Possibility of vancomycin-resistant enterococci transmission from human to broilers, and possibility of using the vancomycin-resistant gram-positive cocci as a model in a screening study of vancomycin-resistant enterococci infection in the broiler chick



Possibility of vancomycin-resistant enterococci transmission from human to broilers, and possibility of using the vancomycin-resistant gram-positive cocci as a model in a screening study of vancomycin-resistant enterococci infection in the broiler chick



Animal Science Journal 77(5): 538-544



In this study, vancomycin-resistant enterococci (VRE) from humans and vancomycin-resistant gram-positive cocci (VRPC) from pigs were examined for their ability to transmit in the chick intestine (Experiment 1). A model study on the spread speed of VRPC was also estimated from chick to chick under semi-production conditions with different administration routes (not inoculated, oral administration to a chick, sprayed on the floor) (Experiment 2). Furthermore, the disappearance of VRPC from their litter with composting processes was examined (Experiment 3). Each of six chicks was inoculated with VRPC or VRE at 1 day old in Experiment 1. All the chicks had VRPC or VRE in their glandular stomach at 22 days of age. In Experiment 2, 6 floor pens covered with sawdust were prepared and 20 chicks were allotted to each pen. The chicks were inoculated with VRPC at 1 day of age. The VRPC were detected in each group in cloacal swabs at 2 days of age (detection rate; 20-80%). And they were also detected in the not-inoculated group. The VRPC detection rate gradually decreased, and detection was rare (0-10%) in the packing chicks (50 days old). VRPC were detected in the litter of each pen in Experiment 2. A composting process was effectively used to eliminate VRPC by the 6th week (Experiment 3).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012811401

Download citation: RISBibTeXText

DOI: 10.1111/j.1740-0929.2006.00383.x


Related references

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). Journal of Antimicrobial ChemoTherapy 52(3): 382-388, 2003

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci. Brazilian Journal of Infectious Diseases 19(1): 58-61, 2015

The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. American Journal of Infection Control 30(1): 40-43, 2002

Statewide surveillance of isolates of vancomycin-resistant gram-positive cocci Genotyping of vancomycin resistant and activity of quinupristin/dalfopristin and other antimicrobials. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 34: 48, 1994

Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clinical Infectious Diseases 35(10): 1139-1146, 2002

Nosocomial vancomycin-resistant enterococcal blood stream infection development in oncology patients colonized with vancomycin-resistant enterococci. Clinical Infectious Diseases 31(1): 278, 2000

Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clinic Proceedings 86(12): 1230-1243, 2011

Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resistant Enterococci. 2011

Accuracy of the vitek system to identify penicillin resistant enterococci and vancomycin resistant gram positive species. Abstracts of the General Meeting of the American Society for Microbiology 91: 371, 1991

In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin. Diagnostic Microbiology and Infectious Disease 14(4): 337-345, 1991

Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?. Clinical Infectious Diseases 43(Suppl. 2): S70-S74, 2006

Prevalence and distribution of VRE (vancomycin resistant enterococci) and VSE (vancomycin susceptible enterococci) strains in the breeding environment. Annals of Agricultural and Environmental Medicine 23(2): 231-236, 2016

Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years. Clinical Infectious Diseases 24(3): 514-515, 1997

Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci. Journal of Medicinal Chemistry 61(1): 286-304, 2018

In vitro activity of GAR-936, a novel glycylcycline, against vancomycin-resistant enterococci, teicoplanin-resistant coagulase-negative staphylococci and vancomycin-intermediate Staphylococcus aureus. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 41: 172-173, 2001